Shelby Wyatt Sinha

Title: Innovations in NIR Imaging by Shelby Wyatt Sinha

Introduction

Shelby Wyatt Sinha is an accomplished inventor based in Nashville, TN. She has made significant contributions to the field of molecular imaging, particularly in the development of targeted near-infrared (NIR) imaging agents. Her work focuses on enhancing therapy efficacy monitoring and deep tissue imaging, which are crucial for advancing cancer treatment.

Latest Patents

Shelby holds a patent for "Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging." This patent encompasses compounds and methods related to NIR molecular imaging, in-vitro and in-vivo functional imaging, therapy/efficacy monitoring, and cancer and metastatic activity imaging. The compounds and methods she developed pertain to the field of peripheral benzodiazepine receptor imaging, metabolic imaging, cellular respiration imaging, and cellular proliferation imaging as targeted agents that incorporate signaling agents. She has 1 patent to her name.

Career Highlights

Shelby is affiliated with Vanderbilt University, where she continues her research and development in the field of imaging technologies. Her innovative work has the potential to significantly impact cancer diagnostics and treatment strategies.

Collaborations

Shelby collaborates with esteemed colleagues, including Darryl J Bornhop and H Charles Manning, who contribute to her research endeavors and enhance the scope of her projects.

Conclusion

Shelby Wyatt Sinha's contributions to NIR imaging represent a significant advancement in medical technology. Her innovative approaches are paving the way for improved cancer treatment and monitoring.